Lucas Paul
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lucas Paul has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Fidele Ntie-Kang
University of Buea
3 shared publications - Angelina I. Makaye
Department of Chemistry, The University of Dodoma, Dodoma, Tanzania, Tanzania
2 shared publications - Yoshua B. Mtulo
Department of Educational Psychology and Curriculum Studies, The University of Dodoma, Dodoma, Tanzania, Tanzania
2 shared publications - Celestin Nzanzu Mudogo
University of Kinshasa Faculty of Medicine: Universite de Kinshasa Faculte de Medecine
1 shared publication Ismail Abubakari
Department of Chemistry, The University of Dodoma, Dodoma, Tanzania
1 shared publication- Kelvin Mark Mtei
Nelson Mandela African Institution of Science and Technology (NM-AIST), School for Materials, Energy, Water, Environmental Science and Engineering, Arusha P.O. Box 447, Tanzania
1 shared publication
Latest Publications
- Open Access
- 13 November 2026
- Published by MDPI AG in Preprints.org
Comparative Computational Analysis of Natural Compounds Against SARS-CoV-2 Spike Protein Structural Conformations
The SARS-CoV-2 Spike glycoprotein plays a critical role in viral entry into host cells through its interaction with the human angiotensin-converting enzyme 2 (ACE2), making it an important target for antiviral drug discovery. This study employed an integrated computational approach to investigate the binding potential of twenty natural compounds against two experimentally determined SARS-CoV-2 Spike protein structures (PDB IDs: 6M17 and 7A91). Molecular docking identified Amentoflavone as the most favourable ref-erence compound against both structures, with binding energies of -10.4 and -9.8 kcal/mol, respectively. Further evaluation of Amentoflavone analogues identified A63 (CHEMBL187504) as a promising candidate, exhibiting more favourable docking scores of approximately -11.3 kcal/mol against 6M17 and -10.1 kcal/mol against 7A91. Molecular dynamics simulations over 100 ns revealed structure-dependent differences in conforma-tional behaviour, residue flexibility, protein compactness, solvent exposure and intermo-lecular hydrogen-bond persistence. MM-PBSA calculations further indicated favourable binding free energies for all four investigated complexes, with 6M17-Amentoflavone (-78.450 ± 13.922 kJ/mol) and 7A91-A63 (-80.769 ± 16.410 kJ/mol) exhibiting the most fa-vourable energetic profiles for their respective structures. Energy decomposition high-lighted van der Waals and electrostatic interactions as major favourable contributors, while residue-wise analysis identified potential amino acid interaction hotspots involved in ligand stabilisation. Overall, the findings demonstrate that Amentoflavone and its ana-logue A63 exhibit promising, structure-dependent computational binding profiles against SARS-CoV-2 Spike protein structures. These findings provide a basis for further structural optimisation and experimental investigations to establish their potential to interfere with Spike-mediated viral entry.
- 13 November 2026
- Published by MDPI AG in Preprints.org
Open AccessComparative Computational Analysis of Natural Compounds Against SARS-CoV-2 Spike Protein Structural Conformations
The SARS-CoV-2 Spike glycoprotein plays a critical role in viral entry into host cells through its interaction with the human angiotensin-converting enzyme 2 (ACE2), making it an important target for antiviral drug discovery. This study employed an integrated computational approach to investigate the binding potential of twenty natural compounds against two experimentally determined SARS-CoV-2 Spike protein structures (PDB IDs: 6M17 and 7A91). Molecular docking identified Amentoflavone as the most favourable ref-erence compound against both structures, with binding energies of -10.4 and -9.8 kcal/mol, respectively. Further evaluation of Amentoflavone analogues identified A63 (CHEMBL187504) as a promising candidate, exhibiting more favourable docking scores of approximately -11.3 kcal/mol against 6M17 and -10.1 kcal/mol against 7A91. Molecular dynamics simulations over 100 ns revealed structure-dependent differences in conforma-tional behaviour, residue flexibility, protein compactness, solvent exposure and intermo-lecular hydrogen-bond persistence. MM-PBSA calculations further indicated favourable binding free energies for all four investigated complexes, with 6M17-Amentoflavone (-78.450 ± 13.922 kJ/mol) and 7A91-A63 (-80.769 ± 16.410 kJ/mol) exhibiting the most fa-vourable energetic profiles for their respective structures. Energy decomposition high-lighted van der Waals and electrostatic interactions as major favourable contributors, while residue-wise analysis identified potential amino acid interaction hotspots involved in ligand stabilisation. Overall, the findings demonstrate that Amentoflavone and its ana-logue A63 exhibit promising, structure-dependent computational binding profiles against SARS-CoV-2 Spike protein structures. These findings provide a basis for further structural optimisation and experimental investigations to establish their potential to interfere with Spike-mediated viral entry.
- Open Access
- 4 June 2026
- Published by MDPI AG in Preprints.org
Structure-Based Virtual Screening and Molecular Dynamics Investigation of Natural Bioactive Compounds Against SARS-CoV-2 Proteins
The continuous emergence of SARS-CoV-2 variants necessitates the identification of effective multi-target antiviral agents with enhanced stability and binding efficiency. This study employed an integrated computational approach, including molecular docking, molecular dynamics (MD) simulations, free energy landscape (FEL) analysis, and Molecular Mechanics Poisson-Boltzmann Surface Area (MM-PBSA) calculations, to evaluate the inhibitory potential of twenty natural compounds against SARS-CoV-2 proteins 7XJW, 8DRW, and 9PFH. Molecular docking identified Amentoflavone as the most promising candidate, exhibiting strong binding affinities toward all targets through favorable hydrogen-bond and hydrophobic interactions within the active sites. Interaction analysis revealed that its biflavonoid scaffold promoted extensive ligand–protein complementarity through hydroxyl and aromatic functional groups. MD simulations demonstrated stable protein-ligand complexes, characterized by low fluctuations in RMSD, RMSF, SASA, and radius of gyration values throughout the 100 ns trajectories. Persistent hydrogen-bond interactions further supported complex stability. FEL analysis revealed compact low-energy conformational basins, indicating thermodynamically favorable binding states. MM-PBSA calculations confirmed favorable binding free energies primarily driven by van der Waals and electrostatic contributions, with the 7XJW-Amentoflavone complex exhibiting the most favorable energetic profile. Overall, these findings highlight Amentoflavone as a promising multi-target inhibitor and potential lead compound for future antiviral drug development and experimental validation against SARS-CoV-2.
- 4 June 2026
- Published by MDPI AG in Preprints.org
Open AccessStructure-Based Virtual Screening and Molecular Dynamics Investigation of Natural Bioactive Compounds Against SARS-CoV-2 Proteins
The continuous emergence of SARS-CoV-2 variants necessitates the identification of effective multi-target antiviral agents with enhanced stability and binding efficiency. This study employed an integrated computational approach, including molecular docking, molecular dynamics (MD) simulations, free energy landscape (FEL) analysis, and Molecular Mechanics Poisson-Boltzmann Surface Area (MM-PBSA) calculations, to evaluate the inhibitory potential of twenty natural compounds against SARS-CoV-2 proteins 7XJW, 8DRW, and 9PFH. Molecular docking identified Amentoflavone as the most promising candidate, exhibiting strong binding affinities toward all targets through favorable hydrogen-bond and hydrophobic interactions within the active sites. Interaction analysis revealed that its biflavonoid scaffold promoted extensive ligand–protein complementarity through hydroxyl and aromatic functional groups. MD simulations demonstrated stable protein-ligand complexes, characterized by low fluctuations in RMSD, RMSF, SASA, and radius of gyration values throughout the 100 ns trajectories. Persistent hydrogen-bond interactions further supported complex stability. FEL analysis revealed compact low-energy conformational basins, indicating thermodynamically favorable binding states. MM-PBSA calculations confirmed favorable binding free energies primarily driven by van der Waals and electrostatic contributions, with the 7XJW-Amentoflavone complex exhibiting the most favorable energetic profile. Overall, these findings highlight Amentoflavone as a promising multi-target inhibitor and potential lead compound for future antiviral drug development and experimental validation against SARS-CoV-2.
- Open Access
- 3 July 2025
- Published by Springer Nature in BMC Chemistry
- Vol. 19 (1) , 1-20
Computational analysis of luteolin, apigenin and their derivatives from Allophylus africanus as potential inhibitors of plasmepsin II a malaria target
Malaria remains a critical global health challenge, especially in Sub-Saharan Africa, with drug-resistant strains heightening the need for new treatment strategies. Plasmepsin II, a key enzyme in the life cycle of malaria presents a promising target for novel antimalarial drugs. This study investigates the interaction of luteolin, apigenin and their glycoside derivatives from Allophylus africanus with PMII target using molecular docking, molecular dynamics simulation and free energy calculations. Luteolin derivatives, particularly luteolin-7-O-glucoside and luteolin-3’,7-di-O-glucoside showed strong binding with PMII at −9.1 and −9.5 kcal/mol, respectively, while in apigenin derivatives apigenin-6,8-di-C-hexoside exhibited the most significant binding energy (−10.2 kcal/mol). The free energy calculations further confirmed the strong binding affinity with the apigenin-8-C-hexoside, demonstrating the best binding free energy (−86.646 kJ/mol). The study highlights the potential of these compounds as promising candidates for antimalarial drug development, although further experimental validation is needed.
- 3 July 2025
- Published by Springer Nature in BMC Chemistry
- Vol. 19 (1) , 1-20
Open AccessComputational analysis of luteolin, apigenin and their derivatives from Allophylus africanus as potential inhibitors of plasmepsin II a malaria target
Malaria remains a critical global health challenge, especially in Sub-Saharan Africa, with drug-resistant strains heightening the need for new treatment strategies. Plasmepsin II, a key enzyme in the life cycle of malaria presents a promising target for novel antimalarial drugs. This study investigates the interaction of luteolin, apigenin and their glycoside derivatives from Allophylus africanus with PMII target using molecular docking, molecular dynamics simulation and free energy calculations. Luteolin derivatives, particularly luteolin-7-O-glucoside and luteolin-3’,7-di-O-glucoside showed strong binding with PMII at −9.1 and −9.5 kcal/mol, respectively, while in apigenin derivatives apigenin-6,8-di-C-hexoside exhibited the most significant binding energy (−10.2 kcal/mol). The free energy calculations further confirmed the strong binding affinity with the apigenin-8-C-hexoside, demonstrating the best binding free energy (−86.646 kJ/mol). The study highlights the potential of these compounds as promising candidates for antimalarial drug development, although further experimental validation is needed.
- Open Access
- 18 April 2020
- Published by Walter de Gruyter GmbH in Physical Sciences Reviews
- Vol. 5 (7)
A computer-based approach for developing linamarase inhibitory agents
Cassava is a strategic crop, especially for developing countries. However, the presence of cyanogenic compounds in cassava products limits the proper nutrients utilization. Due to the poor availability of structure discovery and elucidation in the Protein Data Bank is limiting the full understanding of the enzyme, how to inhibit it and applications in different fields. There is a need to solve the three-dimensional structure (3-D) of linamarase from cassava. The structural elucidation will allow the development of a competitive inhibitor and various industrial applications of the enzyme. The goal of this review is to summarize and present the available 3-D modeling structure of linamarase enzyme using different computational strategies. This approach could help in determining the structure of linamarase and later guide the structure elucidationin silicoand experimentally.
- 18 April 2020
- Published by Walter de Gruyter GmbH in Physical Sciences Reviews
- Vol. 5 (7)
Open AccessA computer-based approach for developing linamarase inhibitory agents
Cassava is a strategic crop, especially for developing countries. However, the presence of cyanogenic compounds in cassava products limits the proper nutrients utilization. Due to the poor availability of structure discovery and elucidation in the Protein Data Bank is limiting the full understanding of the enzyme, how to inhibit it and applications in different fields. There is a need to solve the three-dimensional structure (3-D) of linamarase from cassava. The structural elucidation will allow the development of a competitive inhibitor and various industrial applications of the enzyme. The goal of this review is to summarize and present the available 3-D modeling structure of linamarase enzyme using different computational strategies. This approach could help in determining the structure of linamarase and later guide the structure elucidationin silicoand experimentally.